Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Jill Roberts Center for Inflammatory Bowel Disease
Explore this Website
Home
About Us
Toggle About Us menu options
Clinical Staff
Research Staff
Contact Us
Newsworthy
Toggle Newsworthy menu options
News and Announcements
Patient Care
Toggle Patient Care menu options
Clinical Services
FAQs
For Your Visit
COVID-19 Information
Nutrition Science
Toggle Nutrition Science menu options
Nutrition FAQs
Food Intolerances
News in IBD Nutrition
Research and Clinical Trials
Toggle Research and Clinical Trials menu options
Clinical Trials
Publications
Weill Cornell Medicine
Care
Discover
Teach
Home
About Us
Newsworthy
Patient Care
Nutrition Science
Research and Clinical Trials
Home
Publications
Publications
Clinical Trials
Publications
Publications
Found 37 results
Author
[
Title
]
Type
Year
Filters:
First Letter Of Last Name
is
J
[Clear All Filters]
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
T
Kiuru M
,
Camp B
,
Adhami K
,
Jacob V
,
Magro C
,
Wildman H
. 2015.
Treatment of metastatic cutaneous Crohn disease with certolizumab.
.
Dermatol Online J. 21(11)
Lima S
,
Gogokhia L
,
Viladomiu M
,
Chou L
,
Putzel G
,
Jin W
,
Pires S
,
Guo C-J
,
Gerardin Y
,
Crawford CV
et al.
. 2021.
Transferable Immunoglobulin A-Coated Odoribacter splanchnicus in Responders to Fecal Microbiota Transplantation for Ulcerative Colitis Limits Colonic Inflammation.
.
Gastroenterology.
Lima S
,
Gogokhia L
,
Viladomiu M
,
Chou L
,
Putzel G
,
Jin W
,
Pires S
,
Guo C-J
,
Gerardin Y
,
Crawford CV
et al.
. 2021.
Transferable Immunoglobulin A-Coated Odoribacter splanchnicus in Responders to Fecal Microbiota Transplantation for Ulcerative Colitis Limits Colonic Inflammation.
.
Gastroenterology.
S
Sedano R
,
Hogan M
,
Nguyen TM
,
Chang J
,
Zou GY
,
Macdonald JK
,
Casteele NVande
,
Hanzel J
,
Crowley E
,
Battat R
et al.
. 2021.
Systematic review and Meta-analysis: Clinical, Endoscopic, Histologic and Safety Placebo Rates in Induction and Maintenance trials of Ulcerative Colitis.
.
J Crohns Colitis.
Jacob V
,
Crawford C
,
Cohen-Mekelburg S
,
Viladomiu M
,
Putzel GG
,
Schneider Y
,
Chabouni F
,
OʼNeil S
,
Bosworth B
,
Woo V
et al.
. 2017.
Single Delivery of High-Diversity Fecal Microbiota Preparation by Colonoscopy Is Safe and Effective in Increasing Microbial Diversity in Active Ulcerative Colitis.
.
Inflamm Bowel Dis. 23(6):903-911.
Battat R
,
Duijvestein M
,
Casteele NVande
,
Singh S
,
Dulai PS
,
Valasek MA
,
Mimms L
,
McFarland J
,
Hester KD
,
Renshaw M
et al.
. 2018.
Serum Concentrations of 7α-hydroxy-4-cholesten-3-one Are Associated With Bile Acid Diarrhea in Patients With Crohn's Disease.
.
Clin Gastroenterol Hepatol.
Montrose DC
,
Scherl EJ
,
Bosworth BP
,
Zhou XKathy
,
Jung B
,
Dannenberg AJ
,
Hla T
. 2013.
S1P₁ localizes to the colonic vasculature in ulcerative colitis and maintains blood vessel integrity.
.
J Lipid Res. 54(3):843-51.
R
Kothary V
,
Scherl EJ
,
Bosworth B
,
Jiang Z-D
,
Dupont HL
,
Harel J
,
Simpson KW
,
Dogan B
. 2013.
Rifaximin resistance in Escherichia coli associated with inflammatory bowel disease correlates with prior rifaximin use, mutations in rpoB, and activity of Phe-Arg-β-naphthylamide-inhibitable efflux pumps.
.
Antimicrob Agents Chemother. 57(2):811-7.
Sandborn WJ
,
Feagan BG
,
Fedorak RN
,
Scherl E
,
Fleisher MR
,
Katz S
,
Johanns J
,
Blank M
,
Rutgeerts P
. 2008.
A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease.
.
Gastroenterology. 135(4):1130-41.
P
Longman RS
,
Talal AH
,
Jacobson IM
,
Albert ML
,
Rice CM
. 2004.
Presence of functional dendritic cells in patients chronically infected with hepatitis C virus.
.
Blood. 103(3):1026-9.
Ghosh G
,
Jacob V
,
Wan D
. 2018.
Plasmablastic Lymphoma in a Patient With Crohn's Disease After Extensive Immunosuppressive Therapy.
.
Clin Gastroenterol Hepatol. 16(4):e41-e42.
N
Longman RS
,
Talal AH
,
Jacobson IM
,
Rice CM
,
Albert ML
. 2005.
Normal functional capacity in circulating myeloid and plasmacytoid dendritic cells in patients with chronic hepatitis C.
.
J Infect Dis. 192(3):497-503.
Lukin DJ
,
Funez-dePagnier G
,
Lima S
,
Lai D
,
Duenas-Bianchi L
,
Ahmed W
,
Jacob V
,
Battat R
,
Scherl E
,
Longman RS
. 2021.
No Durable Impact of COVID-19 on Intestinal Disease Activity in Subjects With IBD.
.
Clin Gastroenterol Hepatol. 19(11):2312-2314.e3.
M
Dogan B
,
Scherl E
,
Bosworth B
,
Yantiss R
,
Altier C
,
McDonough PL
,
Jiang Z-D
,
Dupont HL
,
Garneau P
,
Harel J
et al.
. 2013.
Multidrug resistance is common in Escherichia coli associated with ileal Crohn's disease.
.
Inflamm Bowel Dis. 19(1):141-50.
Stathopoulos C
,
Jacquin-Becker C
,
Becker HD
,
Li T
,
Ambrogelly A
,
Longman R
,
Söll D
. 2001.
Methanococcus jannaschii prolyl-cysteinyl-tRNA synthetase possesses overlapping amino acid binding sites.
.
Biochemistry. 40(1):46-52.
I
Ma C
,
Sedano R
,
Almradi A
,
Casteele NVande
,
Parker CE
,
Guizzetti L
,
Schaeffer DF
,
Riddell RH
,
Pai RK
,
Battat R
et al.
. 2021.
An International Consensus to Standardize Integration of Histopathology in Ulcerative Colitis Clinical Trials.
.
Gastroenterology. 160(7):2291-2302.
Ma C
,
Battat R
,
Dulai PS
,
Parker CE
,
Sandborn WJ
,
Feagan BG
,
Jairath V
. 2019.
Innovations in Oral Therapies for Inflammatory Bowel Disease.
.
Drugs. 79(12):1321-1335.
Dulai PS
,
Battat R
,
Barsky M
,
Nguyen NH
,
Ma C
,
Narula N
,
Mosli M
,
Casteele NVande
,
Boland BS
,
Prokop L
et al.
. 2020.
Incorporating Fecal Calprotectin Into Clinical Practice for Patients With Moderate-to-Severely Active Ulcerative Colitis Treated With Biologics or Small-Molecule Inhibitors.
.
Am J Gastroenterol. 115(6):885-894.
Battat R
,
Lukin D
,
Scherl EJ
,
Pola S
,
Kumar A
,
Okada L
,
Yang L
,
Jain A
,
Siegel CA
. 2021.
Immunogenicity of Tumor Necrosis Factor Antagonists and Effect of Dose Escalation on Anti-Drug Antibodies and Serum Drug Concentrations in Inflammatory Bowel Disease.
.
Inflamm Bowel Dis. 27(9):1443-1451.
Viladomiu M
,
Kivolowitz C
,
Abdulhamid A
,
Dogan B
,
Victorio D
,
Castellanos JG
,
Woo V
,
Teng F
,
Tran NL
,
Sczesnak A
et al.
. 2017.
IgA-coated enriched in Crohn's disease spondyloarthritis promote T17-dependent inflammation.
.
Sci Transl Med. 9(376)
H
Battat R
,
Duijvestein M
,
Guizzetti L
,
Choudhary D
,
Boland BS
,
Dulai PS
,
Parker CE
,
Nguyen TM
,
Singh S
,
Casteele NVande
et al.
. 2019.
Histologic Healing Rates of Medical Therapies for Ulcerative Colitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
.
Am J Gastroenterol. 114(5):733-745.
E
Gogokhia L
,
Buhrke K
,
Bell R
,
Hoffman B
,
D Brown G
,
Hanke-Gogokhia C
,
Ajami NJ
,
Wong MC
,
Ghazaryan A
,
Valentine JF
et al.
. 2019.
Expansion of Bacteriophages Is Linked to Aggravated Intestinal Inflammation and Colitis.
.
Cell Host Microbe. 25(2):285-299.e8.
Dogan B
,
Belcher-Timme HFacey
,
Dogan EI
,
Jiang Z-D
,
Dupont HL
,
Snyder N
,
Yang S
,
Chandler B
,
Scherl EJ
,
Simpson KW
. 2018.
Evaluation of Escherichia coli pathotypes associated with irritable bowel syndrome.
.
FEMS Microbiol Lett. 365(22)
Lukin DJ
,
Lawlor G
,
Hudesman DP
,
Durbin L
,
Axelrad JE
,
Passi M
,
Cavaliere K
,
Coburn E
,
Loftus M
,
Jen H
et al.
. 2019.
Escalation of Immunosuppressive Therapy for Inflammatory Bowel Disease Is Not Associated With Adverse Outcomes After Infection With Clostridium difficile.
.
Inflamm Bowel Dis. 25(4):775-781.
Gerbarg PL
,
Jacob VE
,
Stevens L
,
Bosworth BP
,
Chabouni F
,
DeFilippis EM
,
Warren R
,
Trivellas M
,
Patel PV
,
Webb CD
et al.
. 2015.
The Effect of Breathing, Movement, and Meditation on Psychological and Physical Symptoms and Inflammatory Biomarkers in Inflammatory Bowel Disease: A Randomized Controlled Trial.
.
Inflamm Bowel Dis. 21(12):2886-96.
1
(current)
2
next ›
last »